이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

통합 건강 서비스(IHS): 1차 진료에서 HIV/성병 검사 및 PrEP 안내를 개선하기 위한 구조적 중재 (IHS)

2026년 11월 12일 업데이트: June Gipson, My Brother's Keeper, Inc.

통합 건강 서비스(IHS): 일차 진료에서 HIV/STI 검진과 PrEP 연계를 개선하기 위한 구조적 중재

The goal of this clinical trial is to learn whether integrating routine, opt-out HIV and STI testing and pre-exposure prophylaxis (PrEP) navigation into primary care increases use of these services among adults ages 18 to 45 receiving care at Federally Qualified Health Centers in Mississippi. The main questions it aims to answer are:

  1. Does the integrated model increase HIV and STI testing compared with standard care?
  2. Does the integrated model increase PrEP navigation activity for eligible patients?
  3. How do patients and clinic staff experience the integrated model in terms of satisfaction, comfort discussing sexual health, and feasibility in daily workflows?

Researchers will compare a standard-care period to a period when the integrated model is in place to see if the integrated model improves service use and patient experience.

Participants will:

  1. Receive usual primary care, with HIV/STI testing and PrEP discussions offered as a routine, opt-out part of care during the integrated period
  2. Be invited, if eligible, to complete a brief survey about their clinic experience
  3. For staff, be invited to take part in a short survey or interview about clinic workflows and the integrated model

연구 개요

상태

아직 모집하지 않음

정황

개입 / 치료

상세 설명

This is a quasi-experimental, mixed-methods implementation study designed to evaluate an integrated sexual and reproductive health (SRH) model that embeds routine, opt-out HIV and sexually transmitted infection (STI) testing and pre-exposure prophylaxis (PrEP) navigation into primary care workflows at two Federally Qualified Health Centers (FQHCs) in Canton and Yazoo City, Mississippi. The study focuses on adults ages 18-45 receiving primary care at participating clinics, a population experiencing high HIV/STI burden and structural barriers to SRH services, including limited routine testing, low PrEP uptake, and fragmented referral pathways. The intervention is informed by the Comprehensive Theory of Integration and aims to normalize HIV/STI testing as part of routine care while strengthening PrEP navigation and care coordination within existing clinic infrastructure.

The intervention operates at the clinic and workflow level rather than at the level of individual randomization. During the standard-care period, HIV/STI testing and PrEP discussions occur based on provider discretion or patient request, supported by existing electronic health record (EHR) prompts. During the integrated-care period, the study implements standing orders for nurses and peer navigators to initiate HIV tests, guideline-aligned STI tests, and PrEP navigation for eligible patients; EHR prompts and templates that cue providers to offer testing and PrEP in an opt-out manner; embedded peer navigation and daily team huddles to support linkage and follow-up; and training and technical assistance to promote culturally responsive, stigma-informed care. These changes are designed to be feasible within typical FQHC staffing and technology constraints.

The study uses a 24-month pre-post design, with a 12-month standard-care phase followed by a 12-month integrated-care phase. Primary quantitative data will be derived from de-identified or limited EHR extracts containing variables such as age, sex, race/ethnicity, visit type, HIV/STI test ordering and completion, PrEP offers and navigation steps, and documented declinations. Additional quantitative data will be collected through brief patient surveys assessing visit experience, satisfaction, comfort discussing sexual health, perceptions of opt-out testing, and experiences with PrEP discussions and navigation. Qualitative data will be obtained via semi-structured key-informant interviews and surveys with medical providers, nurses/medical assistants, patient navigators and community health workers, and clinic administrators, as well as interviews with a subset of patients, to explore implementation processes, barriers and facilitators, perceived impact, and sustainability.

No experimental drugs or devices are used, and all HIV/STI testing and PrEP services adhere to current clinical guidelines as part of routine care. The research procedures consist of (1) implementing and monitoring the integrated workflow; (2) abstracting EHR data under an IRB-approved waiver of consent and, where applicable, HIPAA authorization; and (3) collecting survey and interview data from patients and staff under informed consent. The primary implementation outcome is change in HIV/STI test uptake among adults ages 18-45 between the standard-care and integrated-care periods. Secondary outcomes include changes in PrEP navigation activity, patient-reported satisfaction and comfort discussing sexual health, provider adoption and fidelity to integrated SRH workflows, and feasibility and acceptability of the intervention from staff and patient perspectives. Analytic plans include pre-post comparisons of service uptake and navigation metrics, as well as thematic analysis of qualitative data to identify contextual factors (e.g., staffing, workflow, stigma, policy environment) that influence successful integration and scalability of the model in high-need FQHC settings.

연구 유형

중재적

등록 (추정된)

700

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 연락처 백업

연구 장소

    • Mississippi
      • Ridgeland, Mississippi, 미국, 39157
        • My Brother's Keeper, Inc.
        • 연락하다:
        • 연락하다:
        • 수석 연구원:
          • June A Gipson, PhD

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 (성인)

건강한 자원 봉사자를 받아들입니다

예

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Adults ages 18 to 45 years.
  • Receiving primary care services at participating Federally Qualified Health Center (FQHC) clinics in Canton or Yazoo City, Mississippi.
  • Able to understand and read English (for participation in surveys and interviews).
  • For staff key informants: current clinical, administrative, or support role at a participating FQHC site with responsibilities related to primary care, HIV/STI services, or care coordination.

Exclusion Criteria:

  • Younger than 18 years or older than 45 years.
  • Critically ill, psychiatrically unstable, or lacking capacity to provide informed consent for research participation.
  • Unable to understand English for consent and survey/interview procedures.
  • For staff key informants: unable or unwilling to provide informed consent for interviews or surveys.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 건강 서비스 연구
  • 할당: 무작위화되지 않음
  • 중재 모델: 단일 그룹 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
간섭 없음: Standard Care

Usual care delivered before implementation of the Integrated Health Services (IHS) model. HIV/STI testing and PrEP navigation occur at provider discretion without standardized workflows or EHR prompts. This represents the 12-month pre-intervention period.

실험적: Integrated HIV/STI and PrEP Care

Care delivered during the 12-month intervention period using the Integrated Health Services (IHS) model, which incorporates routine opt-out HIV/STI screening, standing orders, EHR prompts, and standardized PrEP navigation workflows

Clinic-level implementation of an integrated sexual and reproductive health model that embeds routine, opt-out HIV and sexually transmitted infection (STI) testing and pre-exposure prophylaxis (PrEP) navigation into primary care at Federally Qualified Health Centers. The intervention includes: (1) standing orders for nurses and peer navigators to initiate HIV/STI testing and PrEP navigation for eligible adults ages 18-45; (2) enhanced electronic health record prompts and templates to support opt-out testing and documentation of offers, completions, and declinations; (3) embedded peer navigation and daily team huddles to coordinate linkage and follow-up; and (4) training and technical assistance for clinic staff on workflows, cultural responsiveness, and stigma-reduction related to sexual health and PrEP.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
HIV Testing Uptake
기간: 12 months during standard-care period and 12 months during integrated-care period

Proportion of primary care visits among adults ages 18-45 at participating FQHC clinics with an HIV test completed (numerator: visits with HIV test completed; denominator: eligible visits for adults 18-45), comparing the standard-care period to the integrated-care period using electronic health record data.

12 months during standard-care period and 12 months during integrated-care period

2차 결과 측정

결과 측정
측정값 설명
기간
STI Testing Uptake
기간: 12 months during standard-care period and 12 months during integrated-care period

Proportion of primary care visits among adults ages 18-45 with at least one guideline-aligned STI test (e.g., chlamydia, gonorrhea, syphilis) completed, comparing the standard-care period to the integrated-care period using electronic health record data.

12 months during standard-care period and 12 months during integrated-care period
PrEP Navigation Activity
기간: 12 months during standard-care period and 12 months during integrated-care period

Proportion of eligible adult patients ages 18-45 with a documented PrEP offer and/or navigation step (e.g., referral, navigation contact, PrEP prescription) during primary care visits, comparing standard-care and integrated-care periods using electronic health record data.

12 months during standard-care period and 12 months during integrated-care period
Patient Satisfaction With Integrated Care
기간: Within 7 days of an index primary care visit during the integrated-care period

Mean composite score on the patient satisfaction survey completed by adults ages 18-45 after a primary care visit during the integrated care period.

Within 7 days of an index primary care visit during the integrated-care period
Staff Feasibility Rating
기간: At 6 and 12 months after initiation of the integrated-care period

Mean feasibility rating score from staff surveys assessing feasibility of the integrated-care workflows.

At 6 and 12 months after initiation of the integrated-care period
Staff Acceptability Rating
기간: Assessed at 6 months and 12 months after initiation of the integrated care period.

Mean acceptability rating score from staff surveys evaluating the acceptability of integrated workflows, including perceived usefulness, appropriateness, and value among providers, nurses/medical assistants, navigators, and administrators.

Assessed at 6 months and 12 months after initiation of the integrated care period.

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

협력자

수사관

  • 수석 연구원: June A Gipson, PhD, My Brother's Keeper, Inc.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2027년 5월 1일

기본 완료 (추정된)

2028년 4월 30일

연구 완료 (추정된)

2028년 8월 1일

연구 등록 날짜

최초 제출

2026년 2월 10일

QC 기준을 충족하는 최초 제출

2026년 2월 27일

처음 게시됨 (실제)

2026년 3월 3일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 17일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 12일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • MBK-IHS-01
  • 3OT2OD035877-01S2 (미국 NIH 보조금/계약)

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

예

IPD 계획 설명

De-identified individual participant data (IPD) that underlie the primary and secondary outcome results (selected EHR variables for adults ages 18-45 and de-identified patient and staff survey responses) will be shared. No direct identifiers or HIPAA-defined identifiers will be included, and small cells will be handled to reduce re-identification risk. IPD will be available within 12 months after publication of the main study findings and for at least 5 years thereafter. Data will be shared with qualified researchers who have a scientifically sound proposal, appropriate ethics/IRB approval, and a signed data use agreement with My Brother's Keeper, Inc. and partner clinics. Data will be provided via secure, encrypted transfer or a controlled-access repository.

IPD 공유 기간

De-identified IPD and supporting documents will be available beginning within 12 months after publication of the primary study results in a peer-reviewed journal or submission of the main results to ClinicalTrials.gov, whichever occurs first. Data will remain available for at least 5 years after initial release, or longer if required by funder or institutional policies. Requests received after that period may be considered on a case-by-case basis depending on data retention and feasibility.

IPD 공유 액세스 기준

De-identified IPD will be shared with qualified researchers at academic, clinical, or public health institutions for analyses that are consistent with the original study aims (for example, secondary implementation, health services, or equity-focused analyses) or address clearly justified, related scientific questions. Requestors must submit a brief research proposal, analysis plan, and evidence of IRB/ethics approval or exemption. Requests will be reviewed by the Principal Investigator and designated study leadership at My Brother's Keeper, Inc. and collaborating institutions to assess scientific merit, feasibility, and consistency with participant privacy protections and data-use agreements. Approved requestors will sign a data-use agreement that prohibits any attempt at re-identification and limits data use to the approved project. Data will be provided via secure, encrypted transfer or a controlled-access data repository.

IPD 공유 지원 정보 유형

  • 연구_프로토콜
  • 수액
  • ICF

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .